Overall Cancer Incidence Not Higher With Medically Assisted Reproduction

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on March 18, 2026.

via HealthDay

WEDNESDAY, March 18, 2026 -- Among women using medically assisted reproduction (MAR), the overall incidence of cancer was comparable to that of the general population, according to a study published online March 10 in JAMA Network Open.

Claire Melissa Vajdic, Ph.D., from University of New South Wales in Sydney, and colleagues compared cancer incidence in MAR-exposed women versus the general population of women. The analysis included 417,984 women (aged 18 to 55 years) who used MAR from 1991 to 2018 (assisted reproductive therapy [ART], 65.7 percent; intrauterine insemination with ovarian stimulation [IUI/OS], 28.9 percent; and ovulation induction using clomiphene citrate [clomiphene citrate], 42.0 percent).

The researchers found that the overall incidence of invasive cancer was comparable with that of the general population for the ART and IUI/OS groups. Risk trended toward elevation for the clomiphene citrate cohort. Across all MAR exposures, the incidence rates of uterine cancer and in situ and invasive melanoma were higher, while lower incidence rates were seen for cervical cancer and cancer of the trachea, bronchus, and lung. For the ART and IUI/OS groups, ovarian cancer incidence was higher. Only the ART cohort had higher in situ breast cancer incidence, but the incidence of invasive breast cancer was not elevated. For invasive cancers with elevated incidence, rate differences were all small (<1 to 6.51 cases per 100,000 person-years).

"Women who've had assisted fertility should continue to participate in routine cancer screening programs they’re eligible for," co-lead author Adrian Raymond Walker, Ph.D., also from University of New South Wales, said in a statement. "And they should discuss their cancer risk with their doctor, to understand how else they can reduce their risk."

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-03-19 01:54

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Overall Cancer Incidence Not Higher With Medically Assisted Reproduction

Read more

Disclaimer

Popular Keywords